Literature DB >> 4909350

Positive fluorescent treponemal antibody reactions in diabetes.

M K Hughes, M H Fusillo, B S Roberson.   

Abstract

In a survey of 129 diabetic patients and 142 normal individuals, a significantly higher percentage of positive reactions in the fluorescent treponemal antibody-200 (FTA-200) test was found among diabetic patients than in the normal population. Absorption of all FTA-200-reactive sera with an extract of Reiter's treponeme eliminated most of the positive reactions in sera from diabetic patients, and three of the five positive reactions detected in sera from apparently normal subjects. On immunoelectrophoresis, precipitin bands developed most frequently between the Reiter sorbent and sera from diabetic patients positive in the FTA-200 test. Serum components responsible for FTA reactivity and precipitin reactions against the sorbent were resistant to treatment with mercaptoethanol, suggesting antibody of the IgG class. Cross-reacting antibodies produced in response to normal treponemal flora, and perhaps acquiring enhanced reactivity by means of nonspecific interacting substances in sera peculiar to the altered physiological state of diabetes, are suggested as possible causes of positive reactions of unabsorbed sera. No correlation could be made between age of the diabetic patient, treatment or duration of the disease, and FTA or precipitin reactivity of the patient's serum.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4909350      PMCID: PMC376704          DOI: 10.1128/am.19.3.425-428.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  9 in total

1.  AN IMPROVED FTA TEST FOR SYPHILIS, THE ABSORPTION PROCEDURE (FTA-ABS).

Authors:  E F HUNTER; W E DEACON; P E MEYER
Journal:  Public Health Rep       Date:  1964-05       Impact factor: 2.792

2.  Treponemal antigens as related to identification and syphilis serology.

Authors:  W E DEACON; E F HUNTER
Journal:  Proc Soc Exp Biol Med       Date:  1962-06

3.  Fluorescent treponemal antibody test. Modification based on quantitation (FTA-200).

Authors:  W E DEACON; E M FREEMAN; A HARRIS
Journal:  Proc Soc Exp Biol Med       Date:  1960-04

4.  [Method permitting the combined study of the electrophoretic and the immunochemical properties of protein mixtures; application to blood serum].

Authors:  P GRABAR; C A WILLIAMS
Journal:  Biochim Biophys Acta       Date:  1953-01

5.  The immunologic response of goats to normal and syphilitic rabbit testicular tissue.

Authors:  J N Miller; J H Bekker; J H DeBruijn; P C Onvlee
Journal:  J Immunol       Date:  1966-08       Impact factor: 5.422

6.  Studies on the fluorescent treponemal antibody (FTA) test.

Authors:  A E Wilkinson; C F Rayner
Journal:  Br J Vener Dis       Date:  1966-03

7.  The antigenic structure of Treponema pallidum, Nichols strain. I. The demonstration, nature and location of specific and shared antigens.

Authors:  J N Miller; J H de Bruijn; J H Bekker; P C Onvlee
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

8.  Treponemal antibodies in non-syphilitic, positive anti-nuclear factor sera.

Authors:  T R Neblett; T K Burnham; L R Merriam; G Fine
Journal:  J Invest Dermatol       Date:  1966-01       Impact factor: 8.551

9.  Antigenic relationships of 14 treponemes demonstrated by immunofluorescence.

Authors:  P E Meyer; E F Hunter
Journal:  J Bacteriol       Date:  1967-03       Impact factor: 3.490

  9 in total
  3 in total

1.  A false-positive FTA-ABS test in a heroin addict.

Authors:  P J Feitelson; A B Junkin
Journal:  Calif Med       Date:  1973-08

Review 2.  Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria.

Authors:  Judith Miklossy
Journal:  J Neuroinflammation       Date:  2011-08-04       Impact factor: 8.322

Review 3.  Common mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation.

Authors:  Judith Miklossy; Patrick L McGeer
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.